Please login to the form below

Not currently logged in
Email:
Password:

New accounts: February

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email nhobson@pmlive.com

Astellas

Pan-European corporate profiling

Corporate

The Choice Group

Boehringer Ingelheim/Lilly UK

Cymbalta

Neurology

Virgo Health PR

Cephalon

Actiq

Pain

TVF Communications

Novartis

Aclasta

CRM

MRM Worldwide

Novartis

Prexige

Osteoarthritic pain

Clew Communications

Novartis

Transplantation portfolio

Transplantation

LeapFrog Medical

Pfizer

Diovan/Codiovan

Hypertension

TVF Communications

Pfizer

Injectable contraceptive

Contraception

Ruder Finn

Roche

Avastin

Oncology

Ketchum

Solvay

Omacor

Cardiology

LeapFrog Medical

UCB Pharma

Equasym XL

ADHD

TVF Communications

2nd September 2008

Share

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...